Channel Medsystems® Secures $14.1M Financing

Congratulations to Rosenman Fellow Bill Malecki, co-founder, COO, and CTO of Channel Medsystems!

>>>>>>>>>>>>>>>>>>>>>>>>>>>>

EMERYVILLE, Calif., Aug. 23, 2017 /PRNewswire/ -- Channel Medsystems, developer of an innovative, physician office-based therapy for heavy menstrual bleeding, announced today that it has secured a $14.1mm Series C-1 financing.  The insider-led round included participation by Third Point Ventures, InCube Ventures, Aperture Venture Partners, Scientific Health Development, Longwood Fund, and Boston Scientific.

Channel Medsystems has developed the Cerene® Cryotherapy Device to treat heavy menstrual bleeding.  Cerene allows women who are finished with childbearing to receive treatment in their gynecologist's office, a more comfortable and less-expensive setting of care than a hospital or surgery center. The Company plans to use this funding to support initiatives leading up to anticipated FDA approval as well as initial preparation for commercial launch.

Read the full press release